Table 2 Outcomes of methylene blue treatment of the three studied groups
Group A (n = 30) | Group B (n = 30) | Group C (n = 30) | p-value | Post hoc | |
|---|---|---|---|---|---|
Time to vasopressor discontinuation (h) | 94.3 ± 17.6 | 73.6 ± 11.6 | 70.1 ± 13.4 | < 0.001* | p1 < 0.001* p2 < 0.001* p3 = 0.644 |
Vasopressor-free days at 28 days | 23 (0–26) | 25 (0–26) | 25 (0–26) | < 0.001* | p1 < 0.001* p2 < 0.001* p3 = 0.891 |
Mechanical ventilation (days) | 5 (1–18) | 5 (1–13) | 4 (1–10) | 0.106 | |
ICU length of stay (days) | 12 (3–27) | 9 (3–19) | 8 (3–17) | 0.373 | |
Hospital stay (days) | 27 (3–42) | 15 (3–23) | 13 (3–22) | 0.292 | |
Mortality rate | 14 (46.7%) | 9 (30.0%) | 6 (20.0%) | 0.083 | |
Hazard Ratio (95% CI) | 1 (Ref) | 0.49 (0.17–1.41) | 0.29 (0.09–0.90) |